Genetically engineered human acetylcholinesterase
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 21, 1997
Issued Date -
N/A
app pub date -
Aug 2, 1993
filing date -
Mar 21, 1989
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Genetically engineered human acetylcholinesterase and antibodies that def the protein are described. These composition may be used in pharmaceutical preparations for treatment and prophylaxis of organo-phosphorous compound poisoning or post-operative apnea. Also described are human cholinesterase DNA probes which may be employed for diagnosing progressing ovarian carcinomas and hemocytopoietic disorders.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully